BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30074149)

  • 1. Enhanced Response of Acute Monocytic Leukemia Cells to Low-dose Cytarabine by 1,25-dihydroxyvitamin D3.
    Guo H; Lin SY; Ren WX; Lei Q; Chen ZC; Zhang L; Li QB
    Curr Med Sci; 2018 Feb; 38(1):35-42. PubMed ID: 30074149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
    Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficiency of GHA priming therapy on patients with acute monocytic leukemia and its mechanism].
    Ji YY; Zhang WG; Chen YX; Zhao XM; He AL; Liu J; Wang JL; Wang FX; Zhang PY; Zhang WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):213-8. PubMed ID: 20137150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expression.
    Jensen HA; Yourish HB; Bunaciu RP; Varner JD; Yen A
    FEBS Open Bio; 2015; 5():789-800. PubMed ID: 26566473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
    Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.
    Harrison JS; Wang X; Studzinski GP
    Oncotarget; 2016 Jun; 7(24):36447-36460. PubMed ID: 27144333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine.
    Walsby EJ; Coles SJ; Knapper S; Burnett AK
    Haematologica; 2011 Mar; 96(3):393-9. PubMed ID: 21134979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine.
    Lu JW; Lin YM; Lai YL; Chen CY; Hu CY; Tien HF; Ou DL; Lin LI
    Med Oncol; 2015 Jul; 32(7):206. PubMed ID: 26087957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine.
    Li X; Yan X; Guo W; Huang X; Huang J; Yu M; Ma Z; Xu Y; Huang S; Li C; Zhou Y; Jin J
    Biomed Pharmacother; 2017 Jun; 90():699-704. PubMed ID: 28419965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
    Zheng R; Wang X; Studzinski GP
    J Steroid Biochem Mol Biol; 2015 Apr; 148():132-7. PubMed ID: 25448741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
    Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW
    Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrate increases apoptosis induced by different antineoplastic drugs in monocytic leukemia cells.
    Ramos MG; Rabelo FL; Brumatti G; Bueno-da-Silva AE; Amarante-Mendes GP; Alvarez-Leite JI
    Chemotherapy; 2004 Nov; 50(5):221-8. PubMed ID: 15528887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel analogs of 1,25-dihydroxyvitamin D
    Nachliely M; Sharony E; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
    Clark CS; Konyer JE; Meckling KA
    Exp Cell Res; 2004 Mar; 294(1):301-11. PubMed ID: 14980523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells.
    Ma J; Li X; Su Y; Zhao J; Luedtke DA; Epshteyn V; Edwards H; Wang G; Wang Z; Chu R; Taub JW; Lin H; Wang Y; Ge Y
    Sci Rep; 2017 Feb; 7():41950. PubMed ID: 28176818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis.
    Liu N; Wang C; Wang L; Gao L; Cheng H; Tang G; Hu X; Wang J
    Int J Mol Med; 2016 Jun; 37(6):1686-96. PubMed ID: 27082972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
    Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
    Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of K
    Lowinus T; Heidel FH; Bose T; Nimmagadda SC; Schnöder T; Cammann C; Schmitz I; Seifert U; Fischer T; Schraven B; Bommhardt U
    Cell Commun Signal; 2019 Jan; 17(1):5. PubMed ID: 30651113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apatinib enhances chemosensitivity of acute myeloid leukemia hl60 cells to cytarabine by inducing apoptosis.
    Pan Q; Wang J; Jiang X; Yang E; Dong L; Gu K
    J BUON; 2019; 24(1):374-381. PubMed ID: 30941994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.